menu
    • menu

    Company profile for Pyxis Oncology

    NEW Drugs in Dev: 7
    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    USP reference standards; highly characterized specimens of drug substances, impurities, excipients, degradation products & more.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    Guizhou Utide Biotechnology Co., Ltd. - Specialized GMP manufacturing for next-generation GLP-1 peptide APIs.

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Pyxis Oncology has assembled a differentiated portfolio of potent biologics, including antibody-drug conjugates (ADCs) and monoclonal antibody (mAb) immunotherapies with the potential to further improve the outcome for patients with cancer. Charting a course to therapeutics for difficult-to-treat cancer. Pyxis is advancing a diverse portfolio of immunotherapies that target broad immune regulatory mechanisms as well as novel im...
    Pyxis Oncology has assembled a differentiated portfolio of potent biologics, including antibody-drug conjugates (ADCs) and monoclonal antibody (mAb) immunotherapies with the potential to further improve the outcome for patients with cancer. Charting a course to therapeutics for difficult-to-treat cancer. Pyxis is advancing a diverse portfolio of immunotherapies that target broad immune regulatory mechanisms as well as novel immune checkpoints with the potential to transform the cancer treatment landscape.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Pyxis OncologyUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    35 Cambridgepark Drive Cambridge
    Telephone
    Telephone
    02140 (617) 221-9059
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://pyxisoncology.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    BePharma

    Not Confirmed

    envelop Contact Supplier

    BePharma

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Pyxis Oncology Names Interim CEO For Strategic Program Continuity
    Pyxis Oncology Names Interim CEO For Strategic Program Continuity

    03 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/03/3230875/0/en/Pyxis-Oncology-Announces-Interim-CEO-Appointment-and-Leadership-Transition-to-Support-Strategic-Focus-and-Program-Continuity.html

    GLOBENEWSWIRE
    03 Feb 2026
    Share Share
    Pyxis Oncology Reports Positive Ph 1 Results For MICVO In Cancer
    Pyxis Oncology Reports Positive Ph 1 Results For MICVO In Cancer

    18 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/18/3207556/0/en/Pyxis-Oncology-Announces-Positive-Preliminary-Phase-1-Data-for-Micvotabart-Pelidotin-MICVO-in-Recurrent-Metastatic-Head-and-Neck-Squamous-Cell-Carcinoma.html

    GLOBENEWSWIRE
    18 Dec 2025
    Share Share
    Pyxis Oncology To Participate In Upcoming Investor Conferences
    Pyxis Oncology To Participate In Upcoming Investor Conferences

    03 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/03/3179791/0/en/Pyxis-Oncology-to-Participate-in-Upcoming-Investor-Conferences.html

    GLOBENEWSWIRE
    03 Nov 2025
    Share Share
    Pyxis Oncology To Unveil MICVO Mechanism Of Action At Medical
    Pyxis Oncology To Unveil MICVO Mechanism Of Action At Medical

    13 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/13/3165794/0/en/Pyxis-Oncology-to-Present-Translational-Data-and-Key-Biology-Findings-Elucidating-the-Mechanism-of-Action-of-MICVO-at-Upcoming-Medical-Meetings.html

    GLOBENEWSWIRE
    13 Oct 2025
    Share Share
    Pyxis Oncology Names Alex Kane Senior VP Of Investor Relations
    Pyxis Oncology Names Alex Kane Senior VP Of Investor Relations

    09 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/09/3164040/0/en/Pyxis-Oncology-Appoints-Alex-Kane-as-Senior-Vice-President-Investor-Relations-Capital-Markets.html

    GLOBENEWSWIRE
    09 Oct 2025
    Share Share
    Pyxis Oncology Reports Inducement Grants Under Nasdaq 5635(c)(4)
    Pyxis Oncology Reports Inducement Grants Under Nasdaq 5635(c)(4)

    30 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/30/3159076/0/en/Pyxis-Oncology-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html

    GLOBENEWSWIRE
    30 Sep 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search